CANCER-RELATED COGNITIVE IMPAIRMENT: Management of CRCI: Edited by Janet Ellis and Elie Isenberg-GrzedaCognitive behavioral therapy for cancer-related cognitive dysfunctionKucherer, Shellya; Ferguson, Robert J.bAuthor Information aUniversity of Pittsburgh Medical Center and Department of Psychiatry, Pittsburgh, Pennsylvania bUniversity of Pittsburgh School of Medicine, Department of Medicine, Division of Hematology-Oncology, Pittsburgh, Pennsylvania, USA Correspondence to Dr Robert J. Ferguson, PhD, Assistant Professor of Medicine, University of Pittsburgh Cancer Institute, Biobehavioral Oncology Program, Hillman Cancer Center, 5115 Centre Avenue, Suite A-140, Pittsburgh, PA 15232, USA. E-mail: email@example.com Current Opinion in Supportive and Palliative Care: March 2017 - Volume 11 - Issue 1 - p 46-51 doi: 10.1097/SPC.0000000000000247 Buy Metrics Abstract Purpose of review To provide the reader with an overview of the cognitive-behavioral conceptualization of cancer-related cognitive dysfunction (CRCD) and how cognitive behavioral therapy (CBT) can play an important role in treatment. Recent findings Recent findings show that Memory and Attention Adaptation Training (MAAT), a CBT developed to help cancer survivors develop adaptive skills to improve daily cognitive performance and emotional coping, may be an efficacious treatment of CRCD and can be delivered through videoconference technology to improve survivor access to care. Summary The etiology of CRCD remains largely undetermined and likely is produced by multiple mechanisms. This can include neuronal death, microvascular damage, inflammatory processes, and psychological factors of perceptions of inadequate cognitive capacity to meet performance demands and related emotional distress. As a result, there are a variety of treatments currently being researched. More research with larger sample sizes, multiple clinicians and multiple sites are needed to confirm efficacy, but CBT approaches such as Memory and Attention Adaptation Training that address multiple psychological factors involved may offer a flexible nonpharmacological approach to CRCD that optimizes quality of life outcomes. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.